No Data
No Data
SK Bioscience Wins Patent Dispute Against Moderna Over MRNA Technology in South Korea
Moderna Options Spot-On: On April 23rd, 78,125 Contracts Were Traded, With 771.89K Open Interest
TD Cowen Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $30
Unusual Options Activity: MMM, BURL and Others Attract Market Bets, MMM V/OI Ratio Reaches 142.9
Express News | Moderna : TD Cowen Cuts Target Price to $30 From $35
China Tariffs 'Won't Be Anywhere Near' 145%: Trump